Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R4878 CJD-F | ||
| By: Bucy | H.B. No. 1791 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the duties of a prescriber issuing an opioid | |
| prescription to treat acute pain. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. The heading to Section 481.07636, Health and | |
| Safety Code, is amended to read as follows: | |
| Sec. 481.07636. PRESCRIBING OPIOID FOR ACUTE PAIN; | |
| PRESCRIPTION LIMITS. | |
| SECTION 2. Section 481.07636, Health and Safety Code, is | |
| amended by adding Subsection (b-1) and amending Subsection (c) to | |
| read as follows: | |
| (b-1) A prescriber who prescribes an opioid to a person for | |
| the treatment of acute pain shall also prescribe to the person an | |
| opioid antagonist. | |
| (c) Subsections [ |
|
| apply to a prescription for an opioid approved by the United States | |
| Food and Drug Administration for the treatment of substance | |
| addiction that is issued by a practitioner for the treatment of | |
| substance addiction. | |
| SECTION 3. Subchapter C, Chapter 481, Health and Safety | |
| Code, is amended by adding Section 481.07637 to read as follows: | |
| Sec. 481.07637. ALTERNATIVE TREATMENTS FOR ACUTE PAIN. (a) | |
| In this section, "acute pain" has the meaning assigned by Section | |
| 481.07636. | |
| (b) When issuing an opioid prescription for acute pain, a | |
| prescriber shall also consider referring or prescribing any of the | |
| following pain management services to a patient, based on the | |
| prescriber's clinical judgment and the availability of the | |
| treatment: | |
| (1) chiropractic treatment; | |
| (2) physical therapies; | |
| (3) occupational therapies; | |
| (4) physical medicine and rehabilitation; or | |
| (5) osteopathic manipulation. | |
| (c) This section does not require that all of the treatments | |
| under Subsection (b) be exhausted before the patient may receive a | |
| prescription for an opioid. | |
| SECTION 4. Section 481.003(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) The director may adopt rules to administer and enforce | |
| this chapter, other than Sections 481.074, 481.075, 481.0755, | |
| 481.0756, 481.076, 481.0761, 481.0762, 481.0763, 481.07635, | |
| 481.07636, 481.07637, 481.0764, 481.0765, 481.0766, 481.0767, | |
| 481.0768, and 481.0769. The board may adopt rules to administer | |
| Sections 481.074, 481.075, 481.0755, 481.0756, 481.076, 481.0761, | |
| 481.0762, 481.0763, 481.07635, 481.07636, 481.07637, 481.0764, | |
| 481.0765, 481.0766, 481.0767, 481.0768, and 481.0769. | |
| SECTION 5. Section 554.051(a-1), Occupations Code, is | |
| amended to read as follows: | |
| (a-1) The board may adopt rules to administer Sections | |
| 481.074, 481.075, 481.0755, 481.0756, 481.076, 481.0761, 481.0762, | |
| 481.0763, 481.07635, 481.07636, 481.07637, 481.0764, 481.0765, | |
| 481.0766, 481.0767, 481.0768, and 481.0769, Health and Safety Code. | |
| SECTION 6. Section 565.003, Occupations Code, as amended by | |
| Chapters 1105 (H.B. 2174) and 1166 (H.B. 3284), Acts of the 86th | |
| Legislature, Regular Session, 2019, is reenacted to read as | |
| follows: | |
| Sec. 565.003. ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING | |
| APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE. Unless | |
| compliance would violate the pharmacy or drug statutes or rules in | |
| the state in which the pharmacy is located, the board may discipline | |
| an applicant for or the holder of a nonresident pharmacy license if | |
| the board finds that the applicant or license holder has failed to | |
| comply with: | |
| (1) Subchapter C, Chapter 481, Health and Safety Code; | |
| (2) Texas substitution requirements regarding: | |
| (A) the practitioner's directions concerning | |
| generic substitution; | |
| (B) the patient's right to refuse generic | |
| substitution; or | |
| (C) notification to the patient of the patient's | |
| right to refuse substitution; | |
| (3) any board rule relating to providing drug | |
| information to the patient or the patient's agent in written form or | |
| by telephone; or | |
| (4) any board rule adopted under Section 554.051(a) | |
| and determined by the board to be applicable under Section | |
| 554.051(b). | |
| SECTION 7. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.